Preview

PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology

Advanced search
Fullscreen

For citation:


Klabukova D.L., Holownia-Voloskova M.E., Davydovskaya M.V., Ermolaeva T.N., Polyakova K.I., Fisun A.G., Kokushkin K.A. Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review. PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology. 2018;11(3):43-56. (In Russ.) https://doi.org/10.17749/2070-4909.2018.11.3-043-056

Views: 141


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)